COVID-19
Coronavirus Disease (COVID-19) and SARS-CoV-2
The novel coronavirus belongs to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigations, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestation include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
Common Symptoms
- Fever
- Fatigue
- Dry Cough
Other Symptoms
- Nasal congestion
- Runny nose
- Sore throat
- Myalgia
- Diarrhea
The COVID-19 virus spreads primarily through close contact with an infected person (within 6 feet) via droplets of saliva or discharge from the nose or mouth when an infected person coughs or sneezes and inhaled through the nose into the lungs.
SARS-CoV-2 IgG/IgM Antibody Detection Kit
Beroni Group has developed the SARS-CoV-2 IgG/IgM antibody detection kit in response to the current global SARS-CoV-2 crisis. Our detection kit is a rapid in vitro diagnostic based on immunochromatographic detection techniques (lateral flow) developed for the qualitative and differential detection of a patient’s IgG and the IgM antibody to SARS-CoV-2 in human whole blood (including ‘fingerstick’ blood), plasma and serum.
This product can be distributed in the EU, where it has received CE-IVD certification and is currently under EUA review by the FDA.
Advantages of the SARS-CoV-2 IgG/IgM antibody detection kit:
- 1. Quick - get results in 10 minutes.
- 2. Simple - reading the results directly.
- 3. Sampling – only a small amount (30 μL) of fingertip blood or venous blood needed for test.
- 4. Self-contained – no need for additional diagnostic equipment.
- 5. High sensitivity and specificity.
Download the user guide for the SARS-CoV-2 IgG/IgM antibody detection kit.
For more information about this product, please send your enquiry to
SARS-CoV-2 IgG/IgM Antigen Detection Kit
Beroni Group is pleased to offer the COVID-19 Antigen Rapid Test Kit in response to the current global COVID crisis.
Our detection kit is a rapid in vitro diagnostic based on immunochromatographic detection techniques (lateral flow) developed for the qualitative and differential detection of COVID-19 (SARS-CoV-2) antigen in nasal or throat swab samples.
This product can be distributed in the EU, where it has received CE-IVD certification.
Advantages of our COVID-19 Antigen Rapid Test Kit
- 1. Quick - get results in 15 minutes.
- 2. Simple - reading the results directly.
- 3. Sampling – nasal or throat swab sampling.
- 4. Self-contained – no need for additional diagnostic equipment.
- 5. High sensitivity and specificity.
Download the document to view additional details about the COVID-19 Antigen Rapid test.